Impact of PIVC Length and Gauge on Catheter Indwell Time

Exclusion Criteria

• •History of pro coagulative state/condition (e.g. previous deep vein thrombosis
• •Current hypertension (e.g., systolic \>139 OR diastolic \>89 mmHg)
• •Currently on any anti-coagulant or platelet inhibitor medication. Use of NSAIDs and aspirin will be documented however not exclusionary.
• •Hemophilia or any current or history of bleeding disorder or tendency
• •Presence or report of current blood borne disease/infection (e.g. hepatitis, HIV, leukemia, lymphoma)
• •Difficult vascular access (i.e., vein must be readily palpable and cannulatable - no less than \~2.55 mm diameter to maintain ≤45% C/V ratio) as indicated by standard 52 of the INS guidelines
• •Allergy or sensitivity to chlorhexidine gluconate, isopropyl alcohol, latex, or skin adhesives
• •BMI \<18.5 kg/m2 or ≥35 kg/m2
• •Positive results for the urine drug screen at screening or check-in (including opiates, methadone, cocaine, amphetamines)
• •History or presence of alcoholism (self-reported) or drug abuse within the past 2 years
• •A current or previous medical, physical, mental/cognitive disorders or anatomical conditions that, in the opinion of the investigator, would place the patient at risk, would make them unable to perform study procedures or has the potential to confound interpretation of the study results. (e.g., musculo-skeletal injury, chronic back pain)
• •Employed by Becton Dickinson, Teleflex Medical, Smiths Medical or B Braun (conflict of interest)